Advertisement

Index by author

February 01, 1995; Volume 47,Issue 2

  1. Bain, C J

    1. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
      K A Wafford, M Kathoria, C J Bain, G Marshall, B Le Bourdellès, J A Kemp and P J Whiting
      Molecular Pharmacology February 1995, 47 (2) 374-380;

  2. Bayless, A V

    1. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
      M J Rogers, X Xiong, R J Brown, D J Watts, R G Russell, A V Bayless and F H Ebetino
      Molecular Pharmacology February 1995, 47 (2) 398-402;

  3. Beavo, J A

    1. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
      J Beltman, D E Becker, E Butt, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
      Molecular Pharmacology February 1995, 47 (2) 330-339;
    2. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
      E Butt, J Beltman, D E Becker, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
      Molecular Pharmacology February 1995, 47 (2) 340-347;

  4. Becker, D E

    1. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
      J Beltman, D E Becker, E Butt, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
      Molecular Pharmacology February 1995, 47 (2) 330-339;
    2. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
      E Butt, J Beltman, D E Becker, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
      Molecular Pharmacology February 1995, 47 (2) 340-347;

  5. Beltman, J

    1. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
      J Beltman, D E Becker, E Butt, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
      Molecular Pharmacology February 1995, 47 (2) 330-339;
    2. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
      E Butt, J Beltman, D E Becker, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
      Molecular Pharmacology February 1995, 47 (2) 340-347;

  6. Benovic, J L

    1. Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases.
      S K Debburman, P Kunapuli, J L Benovic and M M Hosey
      Molecular Pharmacology February 1995, 47 (2) 224-233;

  7. Blumberg, P M

    1. Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytes.
      Z Szallasi, K Kosa, C B Smith, A A Dlugosz, E K Williams, S H Yuspa and P M Blumberg
      Molecular Pharmacology February 1995, 47 (2) 258-265;

  8. Bock, M D

    1. Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists.
      L Pradier, E Habert-Ortoli, L Emile, J Le Guern, I Loquet, M D Bock, J Clot, L Mercken, V Fardin and C Garret
      Molecular Pharmacology February 1995, 47 (2) 314-321;

  9. Bonfils, C

    1. Oxidative metabolism of lansoprazole by human liver cytochromes P450.
      L Pichard, R Curi-Pedrosa, C Bonfils, E Jacqz-Aigrain, J Domergue, H Joyeux, J Cosme, F P Guengerich and P Maurel
      Molecular Pharmacology February 1995, 47 (2) 410-418;

  10. Brown, R J

    1. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
      M J Rogers, X Xiong, R J Brown, D J Watts, R G Russell, A V Bayless and F H Ebetino
      Molecular Pharmacology February 1995, 47 (2) 398-402;
« Previous (Pages : 1 2 3 4 5 6 ... 14) Next »
Back to top

In this issue

Advertisement